Published in Hematology Week, October 15th, 2007
All of the SCOR recipients will receive $1.25 million per year for five years, for a total of $6.25 million.
The innovative SCOR program brings together teams of researchers representing different disciplines in a collaborative effort to discover new approaches to treat patients with leukemia, lymphoma and myeloma. Awards go to those groups that best...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hematology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.